Concepedia

Martin Brandenburg

MB

4

Publications

366

Citations

4

H-Index

2004

Active since

Affiliations

Cancer Research UK Manchester Institute(Current)

University of Manchester

Martin Brandenburg is an author at Cancer Research UK Manchester Institute specializing in apoptosis, medicine, and cell biology.

Top concepts

MedicineApoptosisCell DeathCell BiologyTumor BiologyCancer BiologyCancer ResearchCancer Cell BiologyOncologyPharmacology

Publications per year

2004–2011

4

Publications

4

Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1

Andreas Marg, Ying Shan, Thomas Meyer et al. · The Journal of Cell Biology · 2004 · 170 citations · Full text

Phosphorylation of Tip60 by GSK-3 Determines the Induction of PUMA and Apoptosis by p53

Céline Charvet, Manuela Wissler, Prisca Brauns‐Schubert et al. · Molecular Cell · 2011 · 118 citations · Full text

Signal Transduction, Signaling Pathway, Cell Regulation +8

Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1

Luke Harrison, Dimitra Micha, Martin Brandenburg et al. · Journal of Clinical Investigation · 2011 · 49 citations · Full text

Apoptosis, Cell Death, Cancer Biology +17

The Novel Bcl-2 Inhibitor ABT-737 Is More Effective in Hypoxia and Is Able to Reverse Hypoxia-Induced Drug Resistance in Neuroblastoma Cells

Tetyana Klymenko, Martin Brandenburg, Christopher J. Morrow et al. · Molecular Cancer Therapeutics · 2011 · 29 citations · Full text

Hypoxia-induced Drug Resistance, Tumor Biology, Medicine +14

Rows per page

1–4 of 4